Stroke constitutes a major global challenge for health policy and healthcare economics. Reducing stroke burden requires extensive knowledge of risk factors and, if applicable, preventive control...
Keywords: Schlaganfall, Epidemiologie, Risikofaktoren, Genetik
01/2006 | Hämostaseologie, SchattauerCerebrovascular disease is caused by ischaemic stroke, intracerebral haemorrhage, subarachnoidal haemorrhage or cerebral vein and sinus thrombosis...
Keywords: Schlaganfall, Ursachen, Klassifikation
01/2006 | Hämostaseologie, SchattauerStandard therapy of acute ischaemic stroke during the first three hours after symptom onset is intravenous thrombolysis...
Keywords: Schlaganfall, Thrombolyse
01/2006 | Hämostaseologie, SchattauerPatients suffering a transient ischaemic attack (TIA) or ischaemic stroke (IS) have a high recurrence risk...
Keywords: Schlaganfall, Sekundärprävention, Thrombozytenfunktionshemmer
01/2006 | Hämostaseologie, SchattauerObjectives: The main objective of this study was to develop and validate a computer-based statistical algorithm that could be translated into a simple scoring system in order to ascertain incident stroke cases using hospital admission medical records data. Methods: The Risk Index Score (RISc) algorithm was developed using data collected prospectively by the Brain Attack Surveillance in Corpus Christi (BASIC) project, 2000...
Keywords: Stroke, epidemiology, screening, surveillance, informatics
01/2006 | Methods of Information in Medicine, SchattauerOBJECTIVES: Accurately predicting disease progress from a set of predictive variables is an important aspect of clinical work...
Keywords: artificial neural network, regression, benchmarking, Prognosis, Stroke
01/2006 | Methods of Information in Medicine, SchattauerProlactin and leptin are newly recognised platelet co-stimulators due to potentiation of ADP-induced platelet aggregation...
Keywords: platelets, CD62p, Stroke, prolactin, leptin
07/2006 | Thrombosis and Haemostasis, SchattauerThe rapid detection of brain injury (neuronal damage in general) is an important parameter in the management of cerebrovascular accidents, especially in hemorrhagic and/or ischemic events...
Keywords: brain injury, dementia, fatty acid-binding protein, heart-type fatty acid-binding protein (H-FABP), Ischemia, neurological disorders, Stroke
08/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterSince early after the introduction of serum ?-glutamyltransferase (GGT) in clinical practice as a reliable and widely employed laboratory test, epidemiological and prospective studies have repeatedly shown that this activity possesses a prognostic value for morbidity and mortality...
Keywords: atherosclerosis, glutathione, myocardial infarction, serum ?-glutamyltransferase, Stroke
10/2004 | Clinical Chemical Laboratory Medicine, Walter de GruyterThe 5,10-methylenetetrahydrofolate reductase (
Keywords: elderly, folate, methylenetetrahydrofolate reductase (MTHFR), mutation, Polymorphism, Stroke
12/2004 | Clinical Chemical Laboratory Medicine, Walter de GruyterThe aim of the study was to determine serum levels of selected matrix metalloproteinases (MMPs) and their natural inhibitors (TIMPs) in the acute phase of different stroke types subdivided according to the Oxfordshire Community Stroke Project (OCSP) classification and the possibility of discriminating stroke types according to their levels...
Keywords: matrix metalloproteinases, Stroke, tissue inhibitor of metalloproteinases
04/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: infection, inflammation, interleukins, Polymorphism, Stroke, tumor necrosis factor
08/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: aging, folate, peripheral arteriopathy, Stroke, vitamin B12
02/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterAssessment of platelet activation after ischemic stroke could be clinically valuable if platelet markers existed that predict the risk of recurrent events and reflect the effect of antiplatelet therapy...
Keywords: Sekundärprophylaxe, Schlaganfall, Thrombozyten, Thrombozyten-aggregationshemmer, Thrombozytendiagnostik
10/2005 | LaboratoriumsMedizin, Walter de Gruyter